PD-L1 expression and tumour microenvironment immune type groups in meningioma

被引:0
|
作者
Turner, C. [1 ,2 ]
Mclay, J. [3 ]
Correia, J. [2 ,4 ]
Highet, B. [5 ]
Curtis, M. [5 ]
Hermans, I. [6 ]
Dragunow, M. [2 ,7 ]
机构
[1] Auckland City Hosp, Dept Anat Pathol, Auckland, New Zealand
[2] Univ Auckland, Neurosurg Res Unit, Ctr Brain Res, Auckland, New Zealand
[3] Univ Auckland, Dept Stat, Fac Sci, Auckland, New Zealand
[4] Auckland City Hosp, Dept Neurosurg, Auckland, New Zealand
[5] Univ Auckland, Dept Anat & Med Imaging, Ctr Brain Res, Auckland, New Zealand
[6] Malaghan Inst Med Res, Wellington, New Zealand
[7] Univ Auckland, Dept Pharmacol, Ctr Brain Res, Auckland, New Zealand
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
70
引用
收藏
页码:142 / 142
页数:1
相关论文
共 50 条
  • [21] Beyond PD-L1 IHC (TMB, Immune Microenvironment)
    Mino-Kenudsen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S97 - S98
  • [22] Educational video: the role of PD-L1 in the local tumour microenvironment
    Preusser, Matthias
    Berghoff, Anna S.
    Thallinger, Christiane
    Zielinski, Christoph C.
    ESMO OPEN, 2016, 1 (06)
  • [23] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2015, 121 : 251 - 259
  • [24] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 251 - 259
  • [25] PD-L1, PD-1, and CTLA-4 mRNA In Situ Expression by Canine Oral Melanoma Cells and Immune Cells of the Tumour Microenvironment
    Foiani, Greta
    Melchiotti, Erica
    Capello, Katia
    Porcellato, Ilaria
    Brachelente, Chiara
    Iussich, Selina
    Giacobino, Davide
    Morello, Emanuela
    Martano, Marina
    Buracco, Paolo
    Vascellari, Marta
    VETERINARY AND COMPARATIVE ONCOLOGY, 2025,
  • [26] Tumour PD-L1 expression and blood biomarkers of activity of adaptive immunity and tumour microenvironment in patients with solid tumours
    Malkova, A.
    Orlova, R. V.
    Zhukova, N.
    Sharoyko, V.
    Kaledina, E.
    Gubal, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1422 - S1422
  • [27] The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma
    Xu, Bin
    Jungbluth, Achim A.
    Frosina, Denise
    Alzumaili, Bayan
    Aleynick, Nathaniel
    Slodkowska, Elzbieta
    Higgins, Kevin
    Ho, Alan
    Morris, Luc
    Ghossein, Ronald
    Katabi, Nora
    HISTOPATHOLOGY, 2019, 75 (05) : 672 - 682
  • [28] Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment
    Quan, Qiuying
    Guo, Lingchuan
    Huang, Lili
    Liu, Zhiju
    Guo, Tianwei
    Shen, Yu
    Ding, Sisi
    Liu, Cuiping
    Cao, Lei
    MEDICINE, 2023, 102 (48) : E36323
  • [29] Association of Expression of PD-L1 with the Tumor Immune Microenvironment in Small Cell Lung Cancer
    Yu, Hui
    Badzio, Andrzej
    Boyle, Theresa A.
    Chan, Dan
    Rivard, Christopher J.
    Lu, Xian
    Kowalewski, Ashley A.
    Ellison, Kim
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S222 - S223
  • [30] Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
    Du, Ziming
    Abedalthagafi, Malak
    Aizer, Ayal A.
    McHenry, Allison R.
    Sun, Heather H.
    Bray, Mark-Anthony
    Viramontes, Omar
    Machaidze, Revaz
    Brastianos, Priscilla K.
    Reardon, David A.
    Dunn, Ian F.
    Freeman, Gordon J.
    Ligon, Keith L.
    Carpenter, Anne E.
    Alexander, Brian M.
    Agar, Nathalie Y.
    Rodig, Scott J.
    Bradshaw, Elizabeth M.
    Santagata, Sandro
    ONCOTARGET, 2015, 6 (07) : 4704 - 4716